200 Participants Needed

Sleep Disturbances for Post-COVID Syndrome

(SCLC Trial)

Recruiting at 1 trial location
RR
Overseen ByRuchi Rastogi, MS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: VA Office of Research and Development
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to understand how sleep problems after COVID-19 affect physical and mental health. Researchers seek to determine if issues like sleep disturbances and sleep apnea (a condition where breathing repeatedly stops and starts during sleep) contribute to ongoing COVID-19 symptoms, also known as post-acute sequelae of SARS-COV-2 infection (PASC). The study will examine sleep, cognitive function, exercise capacity, and lung function in individuals who had COVID-19. Those who had COVID-19 and have or suspect they have sleep apnea might be suitable candidates for this trial. As an unphased trial, this study offers a unique opportunity to contribute to understanding the long-term effects of COVID-19 on sleep and overall health.

Why are researchers excited about this trial?

Researchers are excited about this trial because it aims to discover predictors of post-COVID-19 clinical and cognitive consequences, which could lead to a better understanding of how to manage and prevent these issues. Unlike existing treatments that primarily address acute COVID-19 symptoms or general cognitive impairments, this research seeks to identify specific factors that influence long-term outcomes. By pinpointing these predictors, healthcare providers could tailor interventions more effectively, potentially improving recovery and quality of life for individuals affected by long COVID.

Who Is on the Research Team?

SC

Susmita Chowdhuri, MD MS

Principal Investigator

John D. Dingell VA Medical Center, Detroit, MI

Are You a Good Fit for This Trial?

Inclusion Criteria

My gender or race does not exclude me from this trial.
I have sleep apnea and had COVID-19 but currently do not have it.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Observational Assessment

Systematic assessment of sleep disturbances, sleep apnea severity, and their impact on PASC-related symptoms

3 months
Regular assessments (in-person and virtual)

Follow-up

Participants are monitored for changes in fatigue, cognitive function, and quality of life

3 months
Follow-up assessments (in-person and virtual)

What Are the Treatments Tested in This Trial?

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials
1,691
Recruited
3,759,000+

John D. Dingell VA Medical Center

Collaborator

Trials
10
Recruited
1,100+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security